Ross Taylor joined Granville Life Sciences to help provide strategic and technical expertise for biopharmaceutical clinical development programs. In his role as CMC Consultant, Ross provides support in the areas of process and analytical development, technology transfer, clinical manufacturing and the generation of regulatory documentation for clients ranging from early-stage biotechs to global life science organizations.

Directly prior to joining Granville, Ross served as a Sr. Director Translational CMC with Icosavax where his primary roles involved leading a team of process/analytical scientists, directly interfacing with CDMOs/CROs for manufacturing development and scale up, and authoring regulatory documentation supporting clinical trials. He has worked in both small biotech and large pharma environments with a number of organizations spanning Phase I to Phase III clinical development with experience in recombinant protein manufacturing, vaccine development and regenerative medicine. In addition to experience with clinical CMC development, Ross has experience with building teams, early-stage pre-clinical development, quality systems and project management.

Ross has extensive industrial experience and is known for his diverse technical experience, a proven manufacturing development history and the ability to manage complex CMC development programs. Ross earned his PhD in Biochemistry and Molecular Biology from Purdue University and conducted academic research at Montana State University prior to the transition to industry.